India to Turkey: Regorafenib Export Trade Route
India has recorded 6 verified shipments of Regorafenib exported to Turkey, representing a combined trade value of $6.0K USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $1.0K USD. The leading Indian exporter is ROYAL MEDICAL PRIVATE LIMITED, which accounts for 41% of total export value with 3 shipments worth $2.5K USD. On the buying side, TO THE ORDER OF INVOICE RAISED TO is the largest importer in Turkey with $2.5K USD in purchases. The top 3 suppliers — ROYAL MEDICAL PRIVATE LIMITED, RAWIA INTERNATIONAL HEALTHCARE PRIVATE LIMITED , M T MADON EXPORTS — together control 92% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Turkey Regorafenib corridor is one of India's established pharmaceutical export routes, with 6 shipments documented worth a combined $6.0K USD. The route is dominated by ROYAL MEDICAL PRIVATE LIMITED, which alone accounts for roughly 41% of all export value, reflecting the consolidated nature of India's regorafenib manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $1.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with regorafenib's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 15.0%, placing it at rank #1 among India's top regorafenib export destinations globally.
On the import side, key buyers of Indian regorafenib in Turkey include TO THE ORDER OF INVOICE RAISED TO, AL HASEM OTOMOTIV TICARET LIMITED S , SLO TIBBI ILAC ITHALAT and 1 others. TO THE ORDER OF INVOICE RAISED TO is the single largest importer with 3 shipments valued at $2.5K USD.
